A Multicenter Randomized Trial of Continuous versus Intermittent beta-Lactam Infusion in Severe Sepsis
Joel M Dulhunty, Jason A Roberts, Joshua S Davis, Steven AR Webb, Rinaldo Bellomo, Charles Gomersall, Charudatt Shirwadkar, Glenn M Eastwood, John Myburgh, David L Paterson, Therese Starr, Sanjoy K Paul, Jeffrey Lipman
American Journal of Respiratory and Critical Care Medicine | AMER THORACIC SOC | Published : 2015
This study was endorsed by the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Australasian Society for Infectious Diseases Clinical Research Network. The authors thank Sia Athanasas (Burns, Trauma and Critical Care Research Centre, The University of Queensland) for financial management; Celia Webby, Ben Phillis, and Ascar Yu (The University of Queensland) for contract administration; Parisa Glass and Dorrilyn Rajbhandari (The George Institute for Global Health) for assistance with study planning; Sharon Micallef (The George Institute for Global Health) for coordination of study monitoring; Maryam Correa, Ann Gould, Meg Harward, Sharon Micallef, and Kelly Thompson (The George Institute for Global Health) and Janine Stuart (Royal Brisbane and Women's Hospital) for study monitoring; Margaret Haughton, Julius Agbeve, Namitha Bobby, and Mayukh Samanta (QIMR Berghofer Medical Research Institute) for contribution to database design, data management, and data analysis; Simon Venville and Jia Qian Xu (Baxter Healthcare Pty Ltd) for preparatory work relating to study drug compounding in New South Wales; Maxine Krause (Royal Brisbane and Women's Hospital) for administrative support; and site pharmacists who assisted with study drug compounding.